Table 1 Drug classes investigated in the present study
Drug Class | Generics | Anatomical TherapeuticChemical (ATC) Classification |
|---|---|---|
COX-inhibitors | NSAIDs | M01A |
Paracetamols | Paracetamol | N02BE01, N02BE51, N02BE71 |
Opioids (strong) | Morphine | N02AA01, N02AA51, N02AG01 |
Oxycodone | N02AA05, N02AJ17–19 | |
Ketobemidone | N02AB01 | |
Pethidine | N02AB02 | |
Fentanyl | N02AB03 | |
Buprenorphine | N02AE01 | |
Tapentadol | N02AX06 | |
Opioids (weak) | Codeine | N02AJ06–09 N02AA59 N02AA79 |
Dextropropoxyphene | N02 AC04 | |
Tramadol | N02AX02 N02AJ13, N02AJ15 | |
Antiepileptics | Gabapentin | N03AX12 |
Pregabalin | N03AX16 | |
Lamotrigine | N03AX09 | |
Topiramate | N03AX11 | |
Tricyclic antidepressants | Amitriptyline | N06AA09 |
Nortriptyline | N06AA10 | |
Antidepressants | Mirtazapine | N06AX11 |
Citalopram | N06AB04 | |
Escitalopram | N06AB10 | |
Fluoxetine | N06AB03 | |
Venlafaxine | N06AX16 | |
Sertraline | N06AB06 | |
Anxiolytics | Diazepam | N05BA01 |
Oxazepam | N05BA04 | |
Lorazepam | N05BA06 | |
Alprazolam | N05BA12 | |
Hypnotics and sedatives | Nitrazepam | N05CD02 |
Flunitrazepam | N05CD03 | |
Midazolam | N05CD08 | |
Other hypnotics, sedatives, and neuroleptics | Haloperidol | N05 AD01 |
Clomethiazole | N05CM02 | |
Zopiclone | N05CF01 | |
Zolpidem | N05CF02 | |
Propiomazine | N05CM06 | |
Hydroxyzine | N05BB01 | |
Risperidone | N05AX08 | |
Levomepromazine | N05AA02 |